LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 58.94 | 770.25 | 2249 | 8444 | 0.2663 | 0.3637 | MN20160304_L02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 61.16 | 770.25 | 2650 | 8892 | 0.2980 | 0.4192 | MN20160304_L02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 61.16 | 770.25 | 2346 | 8892 | 0.2638 | 0.3711 | MN20160304_L02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 63.39 | 770.25 | 2721 | 9326 | 0.2918 | 0.4202 | MN20160304_L02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 63.39 | 770.25 | 2334 | 9326 | 0.2503 | 0.3609 | MN20160304_L02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 65.61 | 770.25 | 2870 | 9736 | 0.2948 | 0.4325 | MN20160304_L02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 65.61 | 770.25 | 2524 | 9736 | 0.2592 | 0.3831 | MN20160304_L02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 67.83 | 770.25 | 2951 | 10078 | 0.2928 | 0.4363 | MN20160304_L02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 67.83 | 770.25 | 2583 | 10078 | 0.2563 | 0.3856 | MN20160304_L02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 70.05 | 770.25 | 3125 | 10413 | 0.3001 | 0.4517 | MN20160304_L02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 70.05 | 770.25 | 2717 | 10413 | 0.2609 | 0.3987 | MN20160304_L02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 72.27 | 770.25 | 3233 | 10730 | 0.3013 | 0.4586 | MN20160304_L02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 72.27 | 770.25 | 2826 | 10730 | 0.2634 | 0.4078 | MN20160304_L02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 74.50 | 770.25 | 3408 | 10991 | 0.3101 | 0.4737 | MN20160304_L02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 74.50 | 770.25 | 2851 | 10991 | 0.2594 | 0.4067 | MN20160304_L02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 76.75 | 770.25 | 3518 | 11262 | 0.3124 | 0.4807 | MN20160304_L02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 76.75 | 770.25 | 3063 | 11262 | 0.2720 | 0.4286 | MN20160304_L02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 78.98 | 770.25 | 3570 | 11518 | 0.3099 | 0.4814 | MN20160304_L02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 78.98 | 770.25 | 3166 | 11518 | 0.2749 | 0.4365 | MN20160304_L02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 81.20 | 770.25 | 3836 | 11766 | 0.3260 | 0.5041 | MN20160304_L02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 81.20 | 770.25 | 3295 | 11766 | 0.2800 | 0.4471 | MN20160304_L02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 83.42 | 770.25 | 3951 | 12031 | 0.3284 | 0.5103 | MN20160304_L02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 83.42 | 770.25 | 3335 | 12031 | 0.2772 | 0.4471 | MN20160304_L02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 85.64 | 770.25 | 4126 | 12287 | 0.3358 | 0.5220 | MN20160304_L02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 85.64 | 770.25 | 3493 | 12287 | 0.2843 | 0.4599 | MN20160304_L02 | N22 |